Agenda - Update on Ii-Key-SARS-CoV-2 vaccine pr
Saturday, May 10, 2025 9:17:36 PM
Post# of 36557
Post# of 36557
(Total Views: 303)
Posted On: 02/04/2021 8:31:25 AM
Agenda -
Update on Ii-Key-SARS-CoV-2 vaccine program
-China Licensing & Research Agreement advances with $100,000payment guarantee and $1 million advance on development funding
-Licensing opportunity for COVID-19 therapeutic antibodies
Yesterday some disappointment was expressed regarding the breadth of this agenda. Remember the agenda can be anything a caller wants it to be. Just ask the question, if mgmt. doesn't address your issue.
Update on Ii-Key-SARS-CoV-2 vaccine program
-China Licensing & Research Agreement advances with $100,000payment guarantee and $1 million advance on development funding
-Licensing opportunity for COVID-19 therapeutic antibodies
Yesterday some disappointment was expressed regarding the breadth of this agenda. Remember the agenda can be anything a caller wants it to be. Just ask the question, if mgmt. doesn't address your issue.
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼